Otolaryngologia — chirurgia głowy i szyi
Wątpliwości i zagrożenia związane z transfuzją
Anemia during sequential induction chemotherapy and chemoradiation for head and neck cancer: the impact of blood transfusion on treatment outcome. (opens new window)
Źródło: Int J Radiat Oncol Biol Phys 2009;73(2):391-8.
Indeks: PubMed 18692326
DOI: 10.1016/j.ijrobp.2008.04.052
https://www.ncbi.nlm.nih.gov/pubmed/18692326 (opens new window)
Transfusion as a predictor of recurrence and survival in head and neck cancer surgery patients. (opens new window)
Źródło: J Otolaryngol Head Neck Surg 2010;39(5):516-22.
Indeks: PubMed 20828514
https://www.ncbi.nlm.nih.gov/pubmed/20828514 (opens new window)
Does transfusion improve the outcome for HNSCC patients treated with radiotherapy?—results from the randomized DAHANCA 5 and 7 trials. (opens new window)
Źródło: Acta Oncol 2011;50(7):1006-14.
Indeks: PubMed 21790306
DOI: 10.3109/0284186X.2011.592650
https://www.ncbi.nlm.nih.gov/pubmed/21790306 (opens new window)
Transfusion of allogenic leukocyte-depleted packed red blood cells is associated with postoperative morbidity in patients undergoing oral and oropharyngeal cancer surgery. (opens new window)
Źródło: Oral Oncol 2012;48(4):372-8.
Indeks: PubMed 22182932
DOI: 10.1016/j.oraloncology.2011.11.020
https://www.ncbi.nlm.nih.gov/pubmed/22182932 (opens new window)